The cell cycle in mammalian cells is regulated by a series of cyclins and cyclin-dependent kinases (CDKs). The G 1 /S checkpoint is mainly dictated by the kinase activities of the cyclin D-CDK4 and/or cyclin D-CDK6 complex and the cyclin E-CDK2 complex. These G 1 kinases can in turn be regulated by cell cycle inhibitors, which may cause the cells to arrest at the G 1 phase. In T-cell hybridomas, addition of anti-T-cell receptor antibody results not only in G 1 arrest but also in apoptosis. In searching for a protein(s) which might interact with Nur77, an orphan steroid receptor required for activation-induced apoptosis of T-cell hybridomas, we have cloned a novel human and mouse CDK inhibitor, p19. The deduced p19 amino acid sequence consists of four ankyrin repeats with 48% identity to p16. The human p19 gene is located on chromosome 19p13, distinct from the positions of p18, p16, and p15. Its mRNA is expressed in all cell types examined. The p19 fusion protein can associate in vitro with CDK4 but not with CDK2, CDC2, or cyclin A, B, E, or D1 to D3. Addition of p19 protein can lead to inhibition of the in vitro kinase activity of cyclin D-CDK4 but not that of cyclin E-CDK2. In T-cell hybridoma DO11.10, p19 was found in association with CDK4 and CDK6 in vivo, although its association with Nur77 is not clear at this point. Thus, p19 is a novel CDK inhibitor which may play a role in the cell cycle regulation of T cells.Apoptosis in immature T cells and T-cell hybridomas, which may relate to negative selection during T-cell development, can be initiated by signals through the T-cell receptor-CD3 complex (18,32,33). This process of activation-induced apoptosis (anti-CD3 apoptosis) consists of two distinct phases. The first phase is the cell cycle block at the G 1 /S transition; it is followed by the second phase, with the generation of apoptotic DNA ladders (18). The second phase requires extracellular calcium and can be inhibited by the immunosuppressive drug cyclosporin A (18). We and others have shown that Nur77 (NGFI-B) orphan steroid receptor is induced during anti-CD3 apoptosis through the calcium signals and it plays an essential role in the cell death process (17, 35). Dominant negative Nur77 can block apoptosis but not the interleukin 2 production of anti-CD3-treated T-cell hybridomas (35). Thus, Nur77 is involved in the second phase of anti-CD3 T-cell apoptosis.As alluded to above, anti-CD3 death in T-cell hybridomas is also accompanied by a G 1 cell cycle block. In all organisms studied so far, cell cycle progression is mediated by cyclindependent kinases (CDKs) that consist of a catalytic subunit CDK and a regulatory subunit cyclin. In mammalian cells, cyclin E-CDK2 together with cyclin D-CDK4 and/or cyclin D-CDK6, which are active in the G 1 phase, control the G 1 -to-S transition (23, 24, 28, 31 and references therein). There are at least three different D-type cyclins, with T cells expressing cyclins D2 and D3 and two cyclin D-associating kinases, CDK4 and CDK6. One of their substrates is the retinobl...